Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23425489 | 0.97 | ANPEP (0.31) | ANPEPDPP4 | |
| SCHEMBL24282818 | 0.97 | ANPEP (0.31) | ANPEPDPP4 | |
| SCHEMBL20436764 | 0.97 | — | — | |
| SCHEMBL20436779 | 0.97 | — | — | |
| SCHEMBL18745535 | 0.92 | — | — | |
| SCHEMBL18746362 | 0.91 | — | — | |
| SCHEMBL18389166 | 0.91 | ANPEP (0.31) | ANPEPDPP4 | |
| SCHEMBL87230 | 0.90 | — | — | |
| SCHEMBL12912878 | 0.87 | — | — | |
| SCHEMBL12180002 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9795953-B2 | Organometallic catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2017-10-24 | — | — | US | disclosed |
| US-20160214098-A1 | NOVEL ORGANOMETALLIC CATALYSTS | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2016-07-28 | — | — | US | disclosed |
| US-9303100-B2 | Organometallic catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2016-04-05 | — | — | US | disclosed |
| US-20150025212-A1 | NOVEL ORGANOMETALLIC CATALYSTS | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2015-01-22 | — | — | US | disclosed |
| EP-1640372-B1 | 1,4-BENZODIOXANE SULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL IND LTD (JP) | 2012-08-01 | — | — | EP | disclosed |
| US-8110636-B1 | Multi-block sulfonated poly(phenylene) copolymer proton exchange membranes | SANDIA CORPORATION (US) | 2012-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160214098-A1 | NOVEL ORGANOMETALLIC CATALYSTS | ZKSCAN2, ZC3HAV1L, ZRANB2 | ANPEP 4297/4885DPP4 3931/4885 |
| US-20150025212-A1 | NOVEL ORGANOMETALLIC CATALYSTS | ZKSCAN2, ZC3HAV1L, ZRANB2 | ANPEP 4297/4885DPP4 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.